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Abstract
Background: Kaposi’s sarcoma-associated herpesvirus (KSHV) glycoprotein B (gB) is not only expressed on the
envelope of mature virions but also on the surfaces of cells undergoing lytic replication. Among herpesviruses,
KSHV gB is the only glycoprotein known to possess the RGD (Arg-Gly-Asp) binding integrin domain critical to
mediating cell attachment. Recent studies described gB to also possess a disintegrin-like domain (DLD) said to
interact with non-RGD binding integrins. We wanted to decipher the roles of two individually distinct integrin
binding domains (RGD versus DLD) within KSHV gB in regulating attachment of cells over cell migration.
Methods: We established HeLa cells expressing recombinant full length gB, gB lacking a functional RGD (gBΔR),
and gB lacking a functionally intact DLD (gBΔD) on their cell surfaces. These cells were tested in wound healing
assay, Transwell migration assay, and adhesion assay to monitor the ability of the RGD and DLD integrin recognition
motifs in gB to mediate migration and attachment of cells. We also used soluble forms of the respective gB
recombinant proteins to analyze and confirm their effect on migration and attachment of cells. The results
from the above studies were authenticated by the use of imaging, and standard biochemical approaches as
Western blotting and RNA silencing using small interfering RNA.
Results: The present report provides the following novel findings: (i) gB does not induce cell migration; (ii) RGD
domain in KSHV gB is the switch that inhibits the ability of DLD to induce cellular migration thus promoting
attachment of cells.
Conclusions: Independently, RGD interactions mediate attachment of cells while DLD interactions regulate
migration of cells. However, when both RGD and DLD are functionally present in the same protein, gB, the RGD
interaction-induced attachment of cells overshadows the ability of DLD mediated signaling to induce migration
of cells. Furthering our understanding of the molecular mechanism of integrin engagement with RGD and DLD
motifs within gB could identify promising new therapeutic avenues and research areas to explore.
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Background
One of the hallmarks of cancer progression is cell attach-
ment, migration, and invasion [1–3]. All of these key fea-
tures are mediated by interactions with integrin-associated
signaling [4]. The most commonly described integrins are
those that recognize a small tripeptide amino acid se-
quence, RGD (Arg-Gly-Asp), and effectively mediate cell
attachment, migration, and invasion [5, 6]. Of late, a small
group of proteins referred to as disintegrins has also been
described to bind integrins [7]. Disintegrins are non-
enzymatic polypeptides broadly distributed in the venoms
of viperid snakes, which antagonize the functions of sev-
eral types of integrin receptors [8]. The minimum compo-
nent of the disintegrin module required for integrin
engagement is the 12- to 13-amino-acid disintegrin loop,
for which a consensus sequence has been described:
RX6DLXXF [9]. We hypothesized that RGD and
disintegrin-like domain (DLD) had distinct roles to play in
regulating attachment and migration of cells.
We employed Kaposi’s sarcoma-associated herpesvirus
(KSHV) encoded glycoprotein B (gB) in functional as-
says to test our hypothesis. KSHV gB possess both of the
aforementioned integrin binding domains. Among the α,
β, and γ herpesvirus gB sequenced to date, KSHV gB
possesses not only the RGD motif but also a functional
disintegrin-like domain (DLD) [10]. Both RGD (27-
29aa) and DLD (66-85aa) are placed juxtaposed in the
N-terminus ectodomain region of the gB. In the case of
KSHV gB, the DLD sequence is RX5-7D/ELXXF/LX5C
(66-85aa; with a conservative D to E substitution).
KSHV gB is not only expressed on the viral envelope but
also on the infected cell membranes [11]. Earlier studies
established the fact that soluble form and membrane as-
sociated full length gB could mediate cell attachment to
extracellular matrix protein (ECM)-coated wells or a
matrigel via binding to RGD-binding integrins [12]. In
the present study, we have attempted to answer the
following questions: (i) Does gB, a protein that possess
both RGD and DLD mediate migration of cells? (ii)
What are the distinct roles of RGD and DLD in promot-
ing attachment and migration of cells? We concluded
that the RGD and DLD interactions with integrins have
distinct roles in affecting the function of a protein. Our
study, for the first time describes RGD domain as a
switch that regulates function of DLD contained within
the same protein (gB) to effectively assist attachment of
cells versus migration. A short discussion on how these
divergent integrin-based interactions will alter KSHV
pathogenesis is also provided.
Methods
Cells
A human cervical cancer HeLa cell line, human umbilical
vein endothelial cells (HUVEC; Invitrogen, Carlsbad, CA),
and Spodoptera frugiperda ovarian cells (Sf9) were propa-
gated as per standard laboratory procedures [10, 13, 14].
Transfection of cells and silencing PIKfyve RNA (SiRNA)
To establish stably transfected HeLa cells expressing
different recombinant gB and gH proteins, cells (5x105
cells) were seeded onto 24 well plates. Post 24 h of
seeding, the cells were transfected with the respective
plasmid DNA using FuGENE HD transfection reagent
(Promega, Madison, WI). These cells were cultured in
selection medium containing 500 μg/ml of G418 from
the second day of transfection for a duration of
8 weeks after which the expression of genes encoding
different gB proteins were confirmed by flow cytome-
try and RT-PCR. At least 2 pools of cells/each plasmid
that were under the selection for about 8 weeks were
tested in our experiments. Expression of PIKfyve was
inhibited by the transfection of HeLa cells which were sta-
bly transfected to express gBΔR with double-stranded
RNA oligonucleotides as described previously [15, 16].
The PIKfyve siRNAs used in this experiment were ob-
tained from GE Healthcare, Dharmacon RNAi & Gene
expression (Lafayette, CO) as the ON-TARGET plus
Smart pool [17]. The nonspecific (NS) siRNAs used were
those described previously [18]. Efficiency of silencing the
gene was confirmed by performing Western blotting at
48 h post transfection using specific antibodies.
Antibodies, inhibitors, and soluble proteins
An antibody to DLD peptide sequence of gB (anti-DLD)
[10], rabbit antibodies to the RGD-containing sequence of
gB (anti-RGD) [19], rabbit antibodies to the C-terminal
domain in gB (anti-gB-C) [19], rabbit anti-gB antibodies
[11], and rabbit anti-gH antibodies [20] were used in this
study. Polyclonal sheep antibodies to PIKfyve (R&D sys-
tems, Minneapolis, MN) and polyclonal rabbit antibodies
to β-actin (Cell Signaling, Beverly, MA) were used in the
Western blotting experiments. Cytochalasin D (Cyto-D)
and Rac-1 inhibitor, NSC23766, purchased from Sigma-
Aldrich, St. Louis, MO were used in this study. His-
tagged, recombinant and soluble KSHV gBΔTM [21],
gBΔTM lacking the RGD (gBΔTM-RGA; referred to
as gBΔTMΔR) [21], and gBΔTM lacking the DLD
(gBΔTMΔD) [10] were expressed and purified from
Sf9 cells as per earlier studies [10]. Vascular endothelial
growth factor (VEGF) purchased from R&D Systems [18]
was used as a positive control in MTTassay.
Cloning of full length forms of recombinant gB
Clones gB/pCDNA3.1(+), gBΔR/pCDNA3.1(+), and gBΔD/
pCDNA3.1(+) encoding the full length gB (2535 bp), gB
lacking a functional RGD, and a functional DLD, respect-
ively, were used in this study. Clone gBΔR mutant was
generated by mutating one of the existing RGD amino acids
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(GAAHSRGDTFQTS; RGD sequence is in bold) of
KSHV gB to alanine (GCG) (GAAHSRGATFQTS;
alanine point mutation is bolded). The point muta-
tions within the RGD sequence of KSHV gB were
achieved by using the gB/pCDNA3.1(+) plasmid as
the dsDNA template and appropriate primers: RGA.F
forward (5’-GCGGCGCACTCGAGGGGTGCCACC
TTTCAGACGTCCAGTT-3′; bolded region depicts
the alanine point mutations to RGD, coding strand)
and RGA.R reverse (5′-AACTGGACGTCTGAAAG
GTGGCACCCCTCGAGTGCGCCGC-3′; bolded region
depicts the alanine point mutations to RGD, non-coding
strand); along with the QuikChange XL site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA) to yield the gBΔR/
pCDNA3.1(+). Clone gBΔD/pCDNA3.1(+) was generated
as described above and using primers described in our
earlier study [10].
Flow cytometry
Flow cytometry was used to monitor expression of gB
and gH on the cells. The trypsinized transfected cells
were washed, incubated in growth medium at 37 °C for
30 min, centrifuged and resuspended in cold PBS. The
entire procedure was performed at +4 °C. Cells were in-
cubated with different antibodies at 4 °C for 30 min,
washed, incubated with FITC conjugated appropriate
secondary IgG at 4 °C for 30 min, washed and analysed
in a FACScan flow cytometer (Becton Dickinson) with
appropriate gating parameters.
In vitro transcription and translation
The IVT of different plasmids was performed using the
[35S]methionine and TNT-coupled rabbit reticulocyte
lysate system (Promega, Madison, WI) with canine pan-
creatic microsomal membranes according to the manu-
facturer's recommendations [11].
Wound healing migration assay
Untransfected, HeLa cells expressing different forms of
gB or gH were grown to 80–90 % confluence in a 1 %
collagen coated 24-well plates. The monolayers of cells
were wounded by performing a scratch with a sterile
1000 μl micropipette tip as described earlier [22]. Cells
were washed with DMEM, and further incubated at 37 °C
in DMEM containing 2 % FBS. Wound closure was
monitored at 16 h post scratch and imaged with a
laser-scanning LSM 510 Carl Zeiss confocal micro-
scope (Magnification, x 20 objective). The open area
(scratch) was quantified with TScratch software [23].
Transwell migration assay
A three-dimensional cell migration assay was performed
using A Transwell 8-mm permeable membrane insert
coated with a 1 % collagen solution (Millipore Corp.,
Billerica, MA). HeLa cells expressing various recombin-
ant gB proteins were cultured for 24 h in serum-free
medium. A 100 μl of 1x106 cells/ml suspension was
added to the upper chamber of 24-well Transwell plates
and complete DMEM medium (containing10% FBS) was
added to the bottom chamber and incubated at 37 °C.
At the end of 16 h incubation, the non-migrated cells on
the upper face of the membrane were removed by using
a sterile cotton swab and migrated cells on the lower
face were fixed in paraformaldehyde, permeabilized by
methanol (100 %) for 10 min, stained with crystal violet
for 30 min and quantitated by microscopy [24].
Cell adhesion assay
Cell adhesion assays were performed as per earlier
methods [21]. Maxisorp 96-well immune plates (Thermo
Scientific, Waltham, MA) were coated with 100 μl of dif-
ferent concentrations of soluble proteins overnight at 4 °C
in PBS. After three washes with sterile PBS, plates were
blocked with 1 % BSA in PBS for 2 h at 4 °C and washed
three times. HeLa cells were trypsinized and seeded into
the protein-coated wells of the plate at a concentration of
2x104 cells/well in a 100 μl volume. The plate contents
were incubated at 37 °C in a 5 % CO2 atmosphere with
100 % humidity for 1 h and washed four times with
serum-free DMEM, and the adherent cells were fixed with
4 % paraformaldehyde in PBS for 30 min at room
temperature. Adherent cells were washed and stained with
0.5 % crystal violet in water with 20 % (vol/vol) methanol
for 15 min at room temperature. After 15 min, the cells
were extensively washed in PBS, dye was extracted with
0.1 M sodium citrate and quantified by the measurement
of absorbance at 595 nm in an ELISA plate reader. In an-
other set of experiments, we incubated protein-coated
wells of the plate with respective antibodies to different
domains of gB prior to seeding cells and monitoring the
adhesion property as per above procedures.
We also performed the above described cell adhesion
assays with HeLa cells expressing gB, gBΔR, and gBΔD
on their cell membranes. The ability of membrane associ-
ated gB to support adhesion of cells was also confirmed
by incubating these cells with specific antibodies to differ-
ent integrin binding domains contained within gB for 1 h
at +4 °C prior to conducting the adhesion assay using
collagen coated wells.
Monitoring dynamic events on the cell membranes
Target cells were washed in phosphate buffered saline
(PBS) and fixed with 3.7 % formaldehyde in PBS for
10 min. The cells were permeabilized with 0.1 % Triton
X-100 in PBS for 3 min, washed in PBS, and blocked in
PBS containing 1 % bovine serum albumin (BSA).
These cells were stained with rhodamine-labeled phal-
loidin (Biotium, Hayward, CA) diluted (as per the
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manufacturer’s recommendations) in PBS for 20 min at
room temperature before being washed, mounted using
SlowFade Antifade Reagent containing DAPI (Life
Technologies, Grand Island, NY), and examined under
Nikon fluorescent microscope using appropriate filters.
The number of filopodial structures on the individual
cells observed under confocal microscope was counted
manually as described in earlier studies [25]. In another
set of experiments, permeabilized cells were sequen-
tially stained with mouse anti-Rac1 IgG2b monoclonal
antibodies (Thermo Scientific) and FITC-labeled appro-
priate secondary antibodies as per our earlier studies
[26]. Following this procedure the cells were further
stained with rhodamine-labeled phalloidin as described
above. This was conducted to appreciate the distribu-
tion of Rac1 in cells expressing different forms of gB in
terms of filopodial extensions.
Measuring active Rac1 by pull-down with GST-Pak1
Rac1/Cdc42 activation assay was done using the
Active Rac1/Cdc42 Pull-Down and Detection kit
(Thermo Scientific Pierce). The assay employs a GST-
fusion protein containing the p21-binding domain of
p21-activated protein kinase 1 (PAK1) to selectively
bind active Rac1/Cdc42 in whole cell lysates. The
active Rac1/Cdc42 from different cell lysates was de-
termined as per the manufacturer’s recommendation.
Briefly, the active Rac1/Cdc42 bound to the glutathi-
one agarose beads was quantified by immunoblot ana-
lysis using anti-Rac1 and anti-Cdc42 monoclonal
antibody (Thermo Scientific Pierce). The value for
active Rac1/Cdc42 collected on the beads was nor-
malized to the concentration of protein in the cell
lysate. On a separate immunoblot, the total Rac1 and
Cdc42 in a sample of the cell lysate was determined
and normalized to the protein concentration. The
normalized results were then expressed as the ratio of
active Rac1/Cdc42 to total Rac1/Cdc42 in the sample.
Cell proliferation assay
Cell proliferation was monitored using the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay
that was performed according to standard procedures [27].
Each experiment was repeated three times. Cell prolifera-
tion was also conducted by the conventional cell counting
technique as per standard protocols [28].
Results
Generating clones of orf8 to express full length gB with
mutations to DLD and RGD
Full length KSHV orf8 is 2535 bp long that encodes a
845aa gB [29]. In earlier studies we had described the
generation of the full length gB protein and its
characterization [11]. In the present study, we used the
gB/pCDNA3.1(+) clone [11] to generate full length gB
lacking the RGD (gBΔR/pCDNA3.1) and DLD (gBΔD/
pCDNA3.1) domains (Fig. 1a). The gBΔR possess a RGA
instead of RGD motif while gBΔD possess a RVCSASIT-
GEAAAANLEQTC instead of RVCSASITGELFRFN-
LEQTC motif. The authenticity of the generated clones
was confirmed by sequencing. This was a crucial step to
characterize a role for DLD and RGD of gB in mediating
cell attachment and migration. The clones of gB/
pCDNA3.1, gBΔR/pCDNA3.1, gBΔD/pCDNA3.1, and
gH/pCDNA3.1 were in vitro transcribed and translated
(IVT) in the presence of the canine microsomal mem-
branes. Rabbit anti-gB antibodies were used to immuno-
precipitate gB from the IVT products. Rabbit anti-gB
antibodies specifically immunoprecipitated both the
glycosylated (126 kDa) and the non-glycosylated
(94 kDa) forms of the full length gB, gBΔR, and gBΔD
(Fig. 1b; lanes 2-4). Rabbit anti-gB antibodies did not
react significantly with IVT products generated using
empty vector (Fig. 1b; lane 1) and gH/pCDNA3.1
(Fig. 1b; lane 5). Pre-immune IgGs failed to immune
precipitate gB from any of the IVT products generated
(Fig. 1b, lanes 6-10). These results demonstrated the
authenticity of the gB clones generated as well as the
specificity of the rabbit anti-gB antibodies to immuno-
precipitate gB from the IVT products.
Full length gB lacking a functional RGD domain promotes
cell migration
Ideally, human microvascular endothelial cells-dermal
(HMVEC-d) would have been used in this study. Unfor-
tunately, we could not use them for the following three
reasons: (i) in our hands, the transfection efficiency
observed was poor [30]; (ii) these primary cells did not
do well upon performing the scratch (wound) com-
pounded by growing them in medium containing 2 %
FBS; (iii) these cells do not support repeated passages
under selection conditions [31]. In order to test the abil-
ity of gB to mediate cell migration, we utilized adherent
HeLa cells [32] primarily because these cells have been
extensively used to study cell migration compared to
HMVEC-d, HFF and 293 cells [33, 34].
HeLa cells were transfected with plasmids encoding
full length gB, gB lacking a functional RGD (gBΔR), gB
lacking a functional DLD (gBΔD), and gH. We used gH
as a control in this study; it is another glycoprotein like
gB encoded by KSHV, lacking a functional RGD motif.
These transfected cells were cultured with selection
medium for 2 months to establish HeLa cells stably ex-
pressing different forms of recombinant proteins. The
recombinant proteins were expressed on 90–95 % of
cells (on the surfaces) as monitored by flow cytometry.
Representative plots are provided showing the expres-
sion of virus encoded different forms of gB and gH on
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